Medpace Holdings, Inc. Financials

Market Capitalization $9.37 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	24.87
Forward PE	26.10
Price to Sales TTM	$4.35
Price to Book MRQ	$16.35
Enterprise to Revenue	4.05
Enterprise to EBITDA	17.98

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	19.31%
Operating Margin	20.32%
Return on Assets TTM	15.45%
Return on Equity TTM	65.83%

Income Statement

Revenue TTM	$2,156,580,096
Revenue per Share TTM	$69.92
Quarterly Revenue Growth	9.30%
Gross Profit TTM	$1,468,161,024
EBITDA	$485,513,000
Net Income to Common TTM	$416,391,008
Diluted EPS TTM	$13.11
Quarterly Earnings Growth YoY	11.70%

Balance Sheet

Total Cash MRQ	$441,436,000
Total Cash per Share MRQ	$15.36
Total Debt MRQ	$
Total Debt to Equity MRQ	25.33
Current Ratio MRQ	0.73
Book Value per Share MRQ	$19.94

Cash Flow

Operating Cash Flow TTM	$581,974,016
Levered Free Cash Flow TTM	$433,280,512

MEDP Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	30,630,799
Float Shares	22,544,631
Avg 10 Volume	505,030
Avg 30 Volume	None
Shares Short	3,094,745
Short Ratio	9.55
Short % of Shares	13.55%
% Held by Insiders	20.55%
% Held by Institutions	91.47%

Stock Price Summary

Beta	1.48
Fifty Two Week Low	$250.05
Fifty Two Week High	$459.77
Fifty Two Week Change	-25.16%
Day 50 MA	$302.38
Day 200 MA	$326.69

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date